Precision Medicine Market Demands, Industry Analysis and Forecast By 2026

0
137
Precision Medicine

A report by ARC estimated that the Precision Medicine Market will surpass $84 billion by 2026, representing an average annual growth rate of 10 percent from 2019 to 2026.

Precision medicine is an approach to patient care that enables physicians to choose medicines that assist patients to understand their disease genetically. This can also be called custom medicine. The report provides analysis of global precision medicine market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.               

Request Free Sample Report Pages for Better Understanding, Download Here

Recent progress in cancer treatment is strongly linked to genomic medicine among all disease classifications. Comprehension of each tumor’s genetic mutations promises to give doctors more capability to prescribe special medication to combat certain kinds of tumor. However, only a few genetic mutations have been correlated with particular tumors and kinds of tumors. Moreover, with the conclusion of the Human Genome project in 2003 and the Precision Medicine initiative in 2015, new scientific, medical and business models were introduced on the precision medicine market. The only concept behind the creation of a solution for precise medicine is to offer population-specific therapies based on its genomic composition.

Clinical Laboratories and Hospitals Governs the Market in Terms of End Use

In precise medicine, clinical labs and hospitals play a significant role. However, in the prediction timeframe, the home care sector is anticipated to experience the fastest growing segment in the forecast year. The market has benefited by increased acceptance and beneficial findings from precise therapy for different illnesses. The development in private health facilities and devices, combined with the inclusion of clever techniques with several health care systems, are also expected to drive the market.

Regional Outlook

The US investments are increasing in the field of precise medicine, the increasing use by government grants; initiatives of cutting-edge methods and a favorable legal environment are the factors that help to promote regional market growth. The precise medicine industries are at the forefront of North America. Furthermore, the increasing incidence of respiratory and oncological conditions as lifestyles change is the primary cause of market demand. Increased health care expenditure and the presence of key operating players in North America will stimulate the growth of businesses.

The global precision medicine market, Europe has retained a significant share and is expected to develop at a constant pace during the forecast period. Increasing use of precise diagnostic devices, electronic health records and drugs prescribed for a particular disease also contribute to the market growth. In addition, European companies are focused on mergers and acquisitions that are intended to encourage the industry growth.

The demand for precision medicinal products is anticipated to increase in Asia Pacific with high CAGR as the incidence of cancer increases and the ageing population. Government, private grants and R&D investors are anticipated to increase market development in precise medicine market. In addition, Asia Pacific will speed up the growth of precise medical companies with the presence of a large patient pool together with enhanced R&D investment.

Contact Here to Get All Published Reports Access at sales@acumenresearchandconsulting.com | +1 407 915 4157 OR +1 408 900 9135

Get More Adjacent Market Reports:

  • Blockchain in Healthcare Market – The global market size is poised to reach over USD 1.7 billion by 2026 and will grow at CAGR 48.1% during the forecast period, 2019-2026.
  • Genetic Testing Market – The global market is expected to grow at noteworthy CAGR around 11 % throughout the forecast period and reach around US$ 18 billion by 2026.
  • Bioinformatics Market Analysis – Global Industry Size, Share, Trends and Forecast, 2014 – 2024

In Latin America, the precise medicine market will be driven by health infrastructure development, population growth and the boom in the technology sector. Factor such as a lack of knowledge about the health of Latin American is expected to curb the precision market growth.

The global precision medicine industry, in Middle East & Africa region has a considerable share. The market is nevertheless anticipated to grow due to large personal investments in the Middle East nations. In addition, the growing prevalence and enhanced public efforts to enhance healthcare contribute to the growth of the economy.

Geographically, Africa has the least share of the global precision medicine market owing to powerful public policies and bad economies. In stable nations like Botswana, Ghana in Africa is gaining momentum with regards to growth, on the other side, the increasing knowledge of the medical industry.

Key Players & Strategies

Major players include in this report are Major players include in this report are Tepnel Pharma Services, Novartis, Qiagen, Biocrates Life Sciences, NanoString Technologies, Roche, Pfizer, Eagle Genomics, Quest Diagnostics, Menarini Silicon Biosystems, Intomics, and Teva Pharmaceutical and Others.

GE Healthcare extended its Healthcare IT Center of Excellence in Szeged, Hungary, in June 2015 to help with the diagnosis of illnesses that are life-threatening, such as liver cancer and other conditions.

Signature Diagnostics AG, a private company headquartered in Potsdam, Germany, was purchased by Roche in February, 2015.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Hydraulic Fracturing
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Precision Medicine Market By Technology
     1.2.2.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Technology (2015-2026)
     1.2.2.2. Global Precision Medicine Market Revenue Share By Technology in 2018
     1.2.2.3. Big Data Analytics
     1.2.2.4. Bioinformatics
     1.2.2.5. Gene Sequencing
     1.2.2.6. Drug Discovery
     1.2.2.7. Companion Diagnostics
     1.2.2.8. Others
   1.2.3. Precision Medicine Market By Application
     1.2.3.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)
     1.2.3.2. Oncology
     1.2.3.3. Immunology
     1.2.3.4. CNS
     1.2.3.5. Respiratory
   1.2.4. Precision Medicine Market By End Use
     1.2.4.1. Global Precision Medicine Market Revenue and Growth Rate Comparison By Application (2015-2026)
     1.2.4.2. Home care
     1.2.4.3. Hospitals
     1.2.4.4. CBM
     1.2.4.5. Clinical Laboratories
     1.2.4.6. Others
   1.2.5. Precision Medicine Market By Geography
     1.2.5.1. Global Precision Medicine Market Revenue and Growth Rate Comparison by Geography (2015-2026)
     1.2.5.2. North AmericaPrecision Medicine Market Revenue and Growth Rate(2015-2026)
     1.2.5.3. EuropePrecision Medicine Market Revenue and Growth Rate(2015-2026)
     1.2.5.4. Asia-PacificPrecision Medicine Market Revenue and Growth Rate(2015-2026)
     1.2.5.5. Latin AmericaPrecision Medicine Market Revenue and Growth Rate(2015-2026)
     1.2.5.6. Middle East and Africa (MEA)Precision Medicine Market Revenueand Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICSAND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Hydraulic Fracturing Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Hydraulic Fracturing Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Hydraulic Fracturing Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Hydraulic Fracturing Major Manufacturers in 2018

CHAPTER 4. PRECISION MEDICINE MARKET BY TECHNOLOGY
4.1. Global Hydraulic Fracturing Revenue By Technology
4.2. Big Data Analytics
   4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. Bioinformatics
   4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Gene Sequencing
   4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Drug Discovery
   4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.6. Companion Diagnostics
   4.6.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.7. Others
   4.7.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   4.7.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. PRECISION MEDICINE MARKET BY APPLICATION
5.1. Global Hydraulic Fracturing Revenue By Application
5.2. Oncology
   5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Immunology
   5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.4. CNS
   5.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   5.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.5. Respiratory
   5.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   5.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. PRECISION MEDICINE MARKET By End Use
6.1. Global Hydraulic Fracturing Revenue By End Use
6.2. Home care
   6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Hospitals
   6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Clinical Laboratories
   6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.5. Others
   6.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA PRECISION MEDICINE MARKET BY COUNTRY
7.1. North America Precision Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Precision Medicine Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   7.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   7.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE PRECISION MEDICINE MARKET BY COUNTRY
8.1. Europe Precision Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   8.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   8.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   8.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   8.6.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   8.7.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PRECISION MEDICINE MARKET BY COUNTRY
9.1. Asia-Pacific Precision Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   9.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   9.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   9.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   9.6.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   9.7.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   9.8.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA PRECISION MEDICINE MARKET BY COUNTRY
10.1. Latin America Precision Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   10.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   10.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   10.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA PRECISION MEDICINE MARKET BY COUNTRY
11.1. Middle East & Africa Precision Medicine Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East & Africa Precision Medicine Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   11.3.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   11.4.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Technology, 2015 – 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Application, 2015 – 2026 ($Million)
   11.5.3. Market Revenue and Forecast By End Use, 2015 – 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Tepnel Pharma Services
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Novartis
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. Qiagen
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. Biocrates Life Sciences
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. NanoString Technologies
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Roche
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Pfizer
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Eagle Genomics
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Type Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Quest Diagnostics
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Type Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Menarini Silicon Biosystems
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Type Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies
12.11. Intomics
   12.11.1. Company Snapshot
   12.11.2. Overview
   12.11.3. Financial Overview
   12.11.4. Type Portfolio
   12.11.5. Key Developments
   12.11.6. Strategies
12.12. Teva Pharmaceutical
   12.12.1. Company Snapshot
   12.12.2. Overview
   12.12.3. Financial Overview
   12.12.4. Type Portfolio
   12.12.5. Key Developments
   12.12.6. Strategies
12.13. Others
   12.13.1. Company Snapshot
   12.13.2. Overview
   12.13.3. Financial Overview
   12.13.4. Type Portfolio
   12.13.5. Key Developments
   12.13.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1588

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.


LEAVE A REPLY

Please enter your comment!
Please enter your name here